For over 1 million adults and children in the United States who suffer from inflammatory bowel disease (IBD), symptoms such as abdominal pain, digestive issues, weight loss and fatigue are an uncomfortable way of life, even with treatment. IBD (a term for two conditions, Crohn’s disease and ulcerative colitis), shows up as chronic inflammation of the gastrointestinal tract. The exact cause of IBD is unknown, but the disease results from a defective immune system.
Trending
- ‘Having women at the top’ drives structural change, advances gender equity in GI (Healio)
- Virgo Launches EndoML: A Revolutionary AI Platform Powered by the EndoDINO Foundation Model (PR Newswire)
- Improved physician ADR from a baseline of less than 26% linked to lower CRC risk (Healio)
- AGA Clinical Practice Update on Endoscopic Enteral Access: Commentary (Gastro Journal)
- Top Gastrointestinal Cancer Research of 2024 (Gastroenterology Advisor)
- How Physicians Can Prepare for a Private Equity Exit with Rob Greer, Founder of SovDoc (State of MedTech)
- World’s largest proteins study ‘invaluable’ for understanding disease – experts (Independent)
- Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes (Fierce Healthcare)